WebAbout SPARC. Today's live share price for SUN PHARMA ADVANCED RESEARCH COMPANY (SPARC) is NSE: ₹ 183.60, BSE: ₹ 183.50 with a current market capitalization of . Sun Pharmaceutical Advanced Research Company Ltd is an international research based pharmaceutical company engaged in creating new drugs and delivery systems. WebSep 14, 2024 · Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, …
Sun Pharma and SPARC Enter into License Agreement for …
WebNov 26, 2024 · Published On Nov 26, 2024 at 05:42 PM IST. New Delhi: Sun Pharma 's research arm Sun Pharma Advanced Research Company (SPARC) Monday announced top-line results of the pivotal BE study for its ... WebSun Pharma Advanced Research Company Limited (SPARC.NS) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed Dow 30 Sun Pharma Advanced Research … pauland enterprises inc
Sun Pharma and SPARC Announce US FDA Approval of XELPROS ... - BioSpace
WebNov 9, 2024 · The Mumbai-based drug maker has inked a pact with Sun Pharma Advanced Research Company to commercialise benzyl alcohol and propylene glycol-free phenobarbital sodium powder for injection in the US. SPARC submitted a new drug application ( NDA ) to the US Food and Drug Administration ( US FDA ) for the said product in February 2024. WebNov 9, 2024 · As per the agreement signed by the two companies, Sun Pharma has agreed to pay SPARC an upfront payment of $10 million. SPARC will also be eligible to receive milestone payments contingent … WebUnder terms of the license agreement, Sun Pharma will pay SPARC an upfront payment of US$ 20 million. SPARC will also be eligible to receive up to US$ 125 million as milestone … paula meehan sample essay leaving cert